CareLit Fachartikel

The role of MEIS1, BTBD9 and MAP2K5/LBXCOR1 in uraemic RLS – a case-control study in patients with end stage renal disease on maintenance hemodialysis

J Plag, B Schormair, W Samtleben, B Müller-Myhsok, T Illig, T Meitinger, J Winkelmann · Aktuelle Neurologie · 2008 · Heft 09

Dokument
1041757
CareLit-ID
Jahr
2008
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Aktuelle Neurologie
Autor:innen
J Plag, B Schormair, W Samtleben, B Müller-Myhsok, T Illig, T Meitinger, J Winkelmann
Ausgabe
Heft 09 / 2008
Seiten
–
Erschienen: 2008-09-02 00:00:00
ISSN
0302-4350

Zusammenfassung

Introduction: An association between idiopathic Restless legs syndrome (iRLS) and intronic and intergenic variants in MEIS1 (Chromosome 2), BTBD9 (Chromosome 9) and MAP2K5/LBXCOR1 (Chromosome 15) was recently shown. RLS is a common complaint of patients with end-stage renal disease (ESRD), but the etiology of uraemic RLS (uRLS) is still unknown. Our aim was to investigate whether these genetic variants play also a role in this entity. Methods: 465 patients regularly undergoing hemodialysis treatment were investigated from ten dialysis centers. RLS was diagnosed using the criteria of the International Restless Le…

Schlagworte

Association Population Diagnosis Dialysis Aktuelle Neurologie